Cell Harvesting System Market Set for Consistent CAGR of 12.2% to 2032, Reports Persistence Market Research

The global cell harvesting system market is expected to grow from USD 6.9 billion in 2025 to USD 15.5 billion by 2032, at a compound annual growth rate (CAGR) of 12.2% during the forecast period (2025-2032). Cell harvesting plays a crucial role in biologic manufacturing by isolating target cells from growth media. Historically dependent on manual methods like centrifugation and depth filtration, this field has evolved significantly with the advent of automation, improving throughput, reliability, and process control. With rising demand for regenerative medicine, personalized therapies, and advancements in cell-based treatments, the market for cell harvesting systems is poised for substantial growth.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/34752

Key Industry Highlights:

The cell harvesting system market is witnessing significant transformation with technological advancements such as automation and integration with artificial intelligence (AI). Automated systems are projected to dominate the market, with a 67.4% market share in 2025. The growth of regenerative medicine, stem cell therapies, and the rise in personalized therapies are among the primary factors driving the need for efficient cell harvesting systems. Additionally, innovations in filtration systems and automated platforms are enhancing efficiency and reducing costs. Strategic partnerships and acquisitions by key players are accelerating market expansion and driving innovation across the industry.

Biopharmaceutical applications, especially for advanced therapies, vaccines, and cell-based treatments, are expected to lead the global market, with North America accounting for 38.6% of the total value share. Expanding biotech hubs in the Asia Pacific region, alongside increasing government investments in regenerative medicine, are likely to boost growth in these regions.

Market Dynamics
Drivers:

The global market for cell harvesting systems is primarily driven by advancements in automation and single-use technologies. Innovations in automated systems have improved scalability, reduced variability, and enhanced workflow efficiency. A notable example includes Thermo Fisher Scientific's DynaSpin Single-Use Centrifuge, which reduces waste and filtration usage, offering a more sustainable approach to cell harvesting. Additionally, the introduction of modular systems like the Sefia platform by Cytiva and Kite (Gilead) is streamlining CAR-T cell therapy manufacturing, thus improving efficiency and minimizing contamination risks. Real-time monitoring and cost-effective production processes, including automated tangential flow filtration (TFF) systems, are further boosting the market's growth.

Restraints:

Despite the growth prospects, the adoption of automated cell harvesting technologies faces several challenges. High equipment costs, legacy systems in place, and regulatory concerns about new technologies are significant barriers. Manual processes, such as centrifugation and filtration, remain entrenched in many facilities due to the high capital investments in existing systems. Additionally, automated systems, such as TFF and continuous centrifuges, require extensive qualification and process development, which can delay adoption. These high upfront costs and the complexity of system integration are major restraints on the global market.

Opportunities:

Emerging cell harvesting solutions present significant opportunities for growth, especially in biomanufacturing and regenerative medicine. Automation in cell culture systems and bioreactors is playing a key role in producing pluripotent stem cells for disease modeling and personalized treatments. New technologies such as the dissolvable microcarrier using IN-AIR MICROFLUIDICSTM technology, introduced by Rousselot and IamFluidics, have streamlined the cell harvesting process for adherent cells, offering scalability for therapies and biologics. Furthermore, robotic arms and AI-driven systems are optimizing cell harvesting by reducing contamination risks and improving yield. With continuous innovations and advancements in AI/ML integration and lab-on-a-chip solutions, the market is poised for growth, especially in the fields of biomanufacturing and regenerative medicine.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/cell-harvesting-system-market.asp

Category-Wise Analysis

Product Insights:

Automated cell harvesters are projected to capture around 67.4% of the market share by 2025, driven by their superior efficiency, precision, and scalability compared to manual systems. These systems reduce human error, improve reproducibility, and allow for high-throughput processing, making them ideal for large-scale applications. The ability to streamline workflows, minimize labor costs, and speed up production processes is critical in meeting the growing demand for advanced cell therapies and personalized medicine. Additionally, increasing investments in automation technologies are propelling the adoption of automated cell harvesters across the healthcare and biotechnology industries.

Application Insights:

Biopharmaceutical applications are expected to hold a significant revenue share in the global cell harvesting system market by 2025. The rapid growth of the biopharmaceutical sector, particularly in the development of monoclonal antibodies, vaccines, and cell-based therapies, is driving the demand for efficient and scalable cell harvesting systems. Cell harvesting plays an integral role in the production of high-quality therapeutic cells, ensuring better yields and product quality. As the demand for personalized medicine and advanced treatments for chronic and complex diseases grows, the biopharmaceutical sector remains a key driver for the adoption of sophisticated cell harvesting technologies.

Regional Insights

North America:

North America is anticipated to dominate the global cell harvesting system market in 2025, holding a 38.6% share. The region benefits from an advanced biopharmaceutical infrastructure, high investments in cell-based research, and a robust regulatory framework. U.S.-based hospitals, biotech firms, and academic institutions are at the forefront of adopting cutting-edge cell harvesting technologies, with a strong emphasis on regenerative medicine and personalized therapies. Collaborative research between academia and industry has played a crucial role in fostering innovation in cell harvesting systems. With increasing research grants and the growth of small biotech companies, North America is expected to continue its dominance in the global market.

Europe:

Europe is becoming a significant player in the cell harvesting system market, driven by supportive regulatory environments and strategic investments in biomanufacturing. The European Union's emphasis on accelerating research and development, along with favorable policies and funding, has reduced entry barriers for new technologies. In 2023, the Deutsche Forschungsgemeinschaft (DFG) established several research centres to enhance biomedical research. Additionally, companies like Novartis are investing heavily in cell culture manufacturing lines in Austria to produce biologics at scale using automated systems. These developments are making Europe a key market for cell harvesting systems, spurred by innovation funding and industrial-scale implementation.

Asia-Pacific:

The Asia-Pacific region is rapidly emerging as a growth hub for the cell harvesting system market, fueled by expanding biotech hubs and rising government investments in regenerative medicine research. Countries like Japan, China, and India are witnessing an increase in research activities and advanced medical research, driving the demand for innovative cell harvesting technologies. FUJIFILM's US$200 million investment in FUJIFILM Cellular Dynamics and FUJIFILM Diosynth Biotechnologies aims to enhance cell therapy capabilities and support the production of advanced therapies. With favorable government policies, growing healthcare infrastructure, and increasing demand for cell-based treatments, Asia-Pacific is poised for significant growth in the coming years.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/34752

Competitive Landscape

The global cell harvesting system market features a mix of established players and startups focused on innovation. Companies are expanding their market presence through technological advancements, strategic partnerships, and mergers and acquisitions. In June 2025, Sphere Fluidics launched the Cyto?Mine Chroma platform, enhancing single-cell analysis by multiplexing fluorescence detection, enabling rapid isolation and harvesting of live cells for biopharma workflows. Additionally, Ori Biotech Ltd. partnered with Fresenius Kabi in December 2024 to integrate the IRO® platform with cell processing systems, streamlining closed cell therapy manufacturing workflows.

Key Players in the Market:

Esco Micro Pte. Ltd.
Sartorius AG
Cytiva (Danaher)
Thermo Fisher Scientific Inc.
Beckman Coulter, Inc.
Corning Incorporated
PerkinElmer
Revvity
Smart MCs PTY LTD
Sphere Fluidics
Novartis
FUJIFILM Corporation

Recent Developments

The cell harvesting system market has seen notable advancements with the development of high-efficiency automated systems. Notably, Thermo Fisher Scientific launched the DynaSpin Single-Use Centrifuge, a more efficient and cost-effective alternative to traditional centrifugation. Furthermore, the integration of artificial intelligence and machine learning in cell harvesting processes is expected to further optimize scalability and production efficiency, leading to improved product yields and reduced contamination risks.

Future Outlook

The global cell harvesting system market is set to witness substantial growth over the next decade. Driven by advancements in automation, AI, and novel cell-harvesting technologies, the market is poised to benefit from the expanding biopharmaceutical sector, regenerative medicine, and personalized therapies. While challenges like high costs and regulatory hurdles remain, the ongoing innovation and strategic collaborations between industry leaders will drive the evolution of the market. As new technologies reduce production costs and improve efficiency, the future of the cell harvesting system market looks promising, with significant opportunities for growth in emerging regions like Asia Pacific.

Read More Related Reports:

Cleanroom Robots In Healthcare Market https://www.persistencemarketresearch.com/market-research/cleanroom-robots-in-healthcare-market.asp
Europe Autogenous Vaccines Market https://www.persistencemarketresearch.com/market-research/europe-autogenous-vaccines-market.asp
North America Extremity Tissue Expanders Market https://www.persistencemarketresearch.com/market-research/north-america-extremity-tissue-expanders-market.asp
Antibody Drug Conjugates Contract Manufacturing Market https://www.persistencemarketresearch.com/market-research/antibody-drug-conjugates-contract-manufacturing-market.asp
Recombinant Proteins Market https://www.persistencemarketresearch.com/market-research/recombinant-proteins-market.asp

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.